Genetic Association of the KLK4 Locus with Risk of Prostate Cancer
暂无分享,去创建一个
H. Samaratunga | A. Spurdle | S. Chambers | J. Aitken | R. Gardiner | J. Batra | F. Lose | P. Heathcote | T. O’Mara | G. Malone | K. Kerr | L. Marquart | T. Yeadon | Srilakshmi Srinivasan | Angus Collins | G. Wood | Megan Turner | A. Eckert | A. Collins | M. Turner | Judith A. Clements | P. Saunders | Trina Pamela Allison Judith Peter Glenn Greg Hema Angus Yeadon Saunders Eckert Clements Heathcote W | Judith A Clements | Pamela Saunders
[1] R. Eeles,et al. Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. , 2013, Urologic oncology.
[2] Y. Homma,et al. Oct1 regulates cell growth of LNCaP cells and is a prognostic factor for prostate cancer , 2012, International journal of cancer.
[3] J. Clements,et al. Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients , 2012, Cancer Immunology, Immunotherapy.
[4] A. Scorilas,et al. Kallikrein‐related peptidase 4 gene (KLK4) in prostate tumors: Quantitative expression analysis and evaluation of its clinical significance , 2011, The Prostate.
[5] John T. Wei,et al. A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. , 2011, The Journal of urology.
[6] W. Willett,et al. Large-scale exploration of gene-gene interactions in prostate cancer using a multistage genome-wide association study. , 2011, Cancer research.
[7] S. Benlloch,et al. Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript , 2011, Human Genetics.
[8] A. Spurdle,et al. Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival. , 2010, Gynecologic oncology.
[9] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[10] S. Chambers,et al. Diagnostic and treatment pathways for men with prostate cancer in Queensland: investigating spatial and demographic inequalities , 2010, BMC Cancer.
[11] J. Clements,et al. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. , 2010, Endocrine reviews.
[12] Andrew J. Vickers,et al. Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer , 2010, Cancer Prevention Research.
[13] M. Wirth,et al. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer , 2010, Biological chemistry.
[14] A. Scorilas,et al. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies. , 2010, Future oncology.
[15] W. Han,et al. Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women. , 2009, Carcinogenesis.
[16] J. Clements,et al. Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer , 2009, Molecular Cancer Research.
[17] Andrew D. Johnson,et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap , 2008, Bioinform..
[18] Christopher Phillips,et al. SPSmart: adapting population based SNP genotype databases for fast and comprehensive web access , 2008, BMC Bioinformatics.
[19] R. Eeles,et al. Reply to “Variation in KLK genes, prostate-specific antigen and risk of prostate cancer” , 2008, Nature Genetics.
[20] M. Thun,et al. Variation in KLK genes, prostate-specific antigen and risk of prostate cancer , 2008, Nature Genetics.
[21] R. Eeles,et al. SNPs in the kallikrein gene region associated with prostate cancer risk: true cause or association by design? , 2008, Nature genetics.
[22] Elaine A. Ostrander,et al. Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium , 2008, Cancer Epidemiology Biomarkers & Prevention.
[23] G. Mize,et al. Prostate-Specific Kallikreins-2 and -4 Enhance the Proliferation of DU-145 Prostate Cancer Cells through Protease-Activated Receptors-1 and -2 , 2008, Molecular Cancer Research.
[24] H. Samaratunga,et al. A novel transcript from the KLKP1 gene is androgen regulated, down‐regulated during prostate cancer progression and encodes the first non‐serine protease identified from the human kallikrein gene locus , 2008, The Prostate.
[25] Ali Amin Al Olama,et al. Multiple newly identified loci associated with prostate cancer susceptibility , 2008, Nature Genetics.
[26] E. Diamandis,et al. A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus , 2007, Molecular oncology.
[27] H. Danielsen,et al. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. , 2007, Cancer research.
[28] P. Fearnhead,et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.
[29] J. Clements,et al. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer , 2007, The Prostate.
[30] C. P. Morris,et al. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. , 2006, Carcinogenesis.
[31] A. Chokkalingam,et al. Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.
[32] H. Samaratunga,et al. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. , 2005, Endocrine-related cancer.
[33] J. Clements,et al. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. , 2005, Endocrine-related cancer.
[34] E. Diamandis,et al. Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids. , 2005, Clinical chemistry.
[35] Thomas Werner,et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites , 2005, Bioinform..
[36] G. Yousef,et al. A survey of alternative transcripts of human tissue kallikrein genes. , 2005, Biochimica et biophysica acta.
[37] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[38] S. Brunak,et al. Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.
[39] M. W. Foster,et al. Integrating ethics and science in the International HapMap Project , 2004, Nature Reviews Genetics.
[40] M. Loda,et al. Kallikrein 4 is a Predominantly Nuclear Protein and Is Overexpressed in Prostate Cancer , 2004, Cancer Research.
[41] I. Kohane,et al. A SNP-centric database for the investigation of the human genome , 2004, BMC Bioinformatics.
[42] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[43] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[44] S. Reed,et al. Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera , 2002, Oncogene.
[45] C. Stephan,et al. Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry. , 2002, Clinical chemistry.
[46] P. Carpenter,et al. A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer. , 2001, Cancer research.
[47] D. Robins,et al. Oct-1 Preferentially Interacts with Androgen Receptor in a DNA-dependent Manner That Facilitates Recruitment of SRC-1* , 2001, The Journal of Biological Chemistry.
[48] G. Yousef,et al. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated. , 1999, Cancer research.
[49] L. Hood,et al. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[51] T. Heinemeyer,et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL , 1998, Nucleic Acids Res..